Thomas was a cheerful and lively toddler whose enthusiasm and curiosity brightened every space he entered. From the start, he was a clingy baby, always wanting to be close to his mother, Abby. As he grew, he transformed into an adventurous little boy, eager to discover the world and fill his days with joy. Life felt normal, happy, and full of potential—until December 2014, when a family vacation at the beach led them down an unexpected path.
It began quietly. At two and a half years old, Thomas started experiencing frequent vomiting and persistent fatigue. His parents, Abby and John, initially thought it was just a minor stomach issue. Visits to their local hospital provided little insight, with doctors attributing it to gastritis. However, the troubling symptoms persisted, and Abby noticed something odd: Thomas’ eye appeared different. Concerned, they decided to take him to Monash Children’s Hospital, where emergency imaging would soon unveil a terrifying truth.

An MRI revealed a lesion on Thomas’ brain—a large mass. Abby recalls the shock vividly. “I always thought of cancer as something that affected older people,” she says. “How could my two-year-old have cancer? That’s absurd.” The news worsened as multiple tumors were found in his brain and spinal cord. Although they were slow-growing, many were inoperable, leaving his parents heartbroken. “We sat in a room. I remember seeing a box of tissues on the table and thinking: ‘What is this room?’” Abby reflects.
Thomas underwent surgery to remove part of the tumor, but a definitive diagnosis remained elusive. Samples were sent to Melbourne and Perth for analysis, yet uncertainty lingered. Meanwhile, Thomas faced severe complications. He needed a shunt to drain fluid from his brain, which frequently blocked, requiring multiple surgeries. He lost a significant amount of his eyesight, causing him to bump into things and struggle with basic mobility. Days turned into weeks, weeks into months, and months into years, as the family grappled with the frustration of unclear treatment options and the pain their son endured.

“As a parent, it was incredibly difficult to process, thinking that there might be no way forward,” Abby shares. “We were devastated.”
In the midst of this despair, Abby and John discovered the Zero Childhood Cancer Program (ZERO), which offered a glimmer of hope. Thomas was accepted into the program, and his tumor underwent comprehensive genomic analysis. Doctors identified a mutation believed to be fueling the cancer and matched Thomas with a targeted therapy drug called Afatinib.
The results were astounding. Within two months of starting treatment, Thomas’ scans showed significant improvement. His energy returned, headaches subsided, and his appetite improved. “I don’t know what we would have done without ZERO. There was no other option for us,” Abby states.

Now, at eight years old, Thomas continues to receive the gene therapy that has given him a chance at life. His tumor has shrunk, and he is no longer in excruciating pain. Although the damage to his eyesight is permanent, Thomas has regained much of the joy and activity typical of a normal childhood. He engages in his favorite hobbies, enjoys family outings, and participates in activities that bring him laughter and energy.
Thomas’ journey is a testament to the resilience of children and the unwavering strength of families confronting life-threatening illnesses. His story highlights the significance of scientific research, especially in personalized medicine for rare and aggressive childhood cancers. Without programs like ZERO, Thomas’ future could have been far less certain.
For Abby and John, every day with Thomas is a treasure, a reminder of the struggles they’ve faced and the victories they’ve achieved together. “Watching him play, laugh, and engage with the world again is incredible,” Abby expresses. “We’ve witnessed him endure unimaginable pain and uncertainty, and now he’s thriving in ways we never thought possible.”

The family continues to live cautiously, with regular check-ups and ongoing monitoring, but hope and gratitude have replaced despair. Thomas’ story serves as a powerful reminder that even in the darkest times, innovation, love, and determination can reshape the future.
Through gene therapy, family support, and the perseverance of an extraordinary little boy, Thomas’ journey embodies courage, resilience, and the remarkable power of hope. From the uncertainty of a devastating diagnosis to the joy of regained health and activity, Thomas has demonstrated that even the smallest warriors can confront immense challenges and emerge stronger, inspiring those around them to believe in miracles and the promise of tomorrow.








